Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report
Tài liệu tham khảo
Ohno, 2003, Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate, Leukemia, 17, 1454, 10.1038/sj.leu.2403031
Shen, 1997, Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients, Blood, 89, 3354, 10.1182/blood.V89.9.3354
Soignet, 2001, United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia, J. Clin. Oncol., 19, 3852, 10.1200/JCO.2001.19.18.3852
Tobita, 1997, Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid, Blood, 90, 967, 10.1182/blood.V90.3.967
Hashimoto, 1995, Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4, J. Cancer Res. Clin. Oncol., 121, 696, 10.1007/BF01218530
Lo-Coco, 2013, Retinoic acid and arsenic trioxide for acute promyelocytic leukemia, N. Engl. J. Med., 369, 111, 10.1056/NEJMoa1300874
Thirugnanam, 2009, Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen, Biol. Blood Marrow Transplant., 15, 1479, 10.1016/j.bbmt.2009.07.010
Gallagher, 2012, Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia, Blood, 120, 2098, 10.1182/blood-2012-01-407601
Côté, 2000, Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia, Blood, 96, 3200, 10.1182/blood.V96.9.3200
Goto, 2011, Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment, Blood, 118, 1600, 10.1182/blood-2011-01-329433